New data shows GSK-Vir drug works against all Omicron mutations

(Reuters) - Britain's GSK released new data on Tuesday from early-stage studies, citing that its antibody-based COVID-19 therapy with U.S. partner Vir...

Related Keywords

Bengaluru ,Karnataka ,India ,United Kingdom ,Britain ,Sherry Jacob Phillips ,Pushkala Aripaka ,Reuters , ,